Dhamotharan Pattarayan
8PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 09, 2026
CRISPR activation screens identify oncogenic lncRNAs that are susceptible to CDK4/6 inhibitor treatment.Yifei Wang, Yueshan Zhao, Jiaxin Hu
|Aug 12, 2025
Cytoplasmic PXR regulates glucose metabolism by binding mRNAs and modulating their stability.Xiaofei Wang, Zehua Wang, Sihan Li
|Aug 12, 2025
The lncRNA EPIC1 suppresses dsRNA-induced type I IFN signaling and is a therapeutic target to enhance TNBC response to PD-1 inhibition.Dhamotharan Pattarayan, Yue Wang, Zehua Wang
|Apr 12, 2024
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer.Yue Wang, Dhamotharan Pattarayan, Haozhe Huang
|Oct 04, 2023
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer.Yue Wang, Dhamotharan Pattarayan, Haozhe Huang
Pageof 2
